je.st
news
Mylan Is Rejected in Bid to Buy Swedish Drugmaker Meda
2014-04-04 20:28:30| Appliances - Topix.net
Mylan Inc., the biggest U.S. generic-drug maker, was rejected in its bid to buy Meda AB, the Swedish pharmaceuticals maker valued at about $4.5 billion.
Tags: buy
bid
swedish
rejected
Category:Consumer Goods and Services
Latest from this category |
All news |
||||||||||||||||||
|